Ces Urol X:X | DOI: 10.48095/cccu2026003

Robot-assisted transvesical prostatectomy – video

Martin Fila Miroslav Záleský Jiří Heráček
Urologická klinika 1. LF UK a ÚVN – VFN, Praha

Introduction: Benign prostatic hyperplasia (BPH) is a common cause of lower urinary tract symptoms. When conservative treatment fails, surgical management is indicated. Robot-assisted transvesical prostatectomy represents a minimally invasive alternative to open surgery. At our department, patients with large adenomas (> 100 mL) are indicated for either HoLEP or robot-assisted transvesical prostatectomy. The procedure is performed using a multi-port system, although recent publications suggest that a single-port approach may represent a promising alternative. A potential advantage of this procedure compared to HoLEP is the avoidance of transurethral instrumentation, which may reduce the risk of urethral strictures and improve early postoperative continence.

Material and methods: We present a case of a 76-year-old male with massive benign prostatic enlargement (142 mL) and chronic urinary retention. Preoperative prostatic specific antigen (PSA) level was 14.3 ng/mL; due to a PSA density of 0.10, prostate biopsy wasn\'t indicated. The procedure was performed in December 2024. The surgical video demonstrates all key steps of the surgery - bladder incision, adenoma enucleation, hemostasis, and bladder reconstruction. Operative time was 85 minutes, and 66 g of prostatic tissue was removed. Histopathology confirmed benign hyperplasia. The patient was discharged on postoperative day three, and the catheter was removed 9 days after surgery. The patient is fully continent, with no postvoid residual urine on ultrasound. Postoperative PSA was 2.09 ng/mL.

Conclusion: Robot-assisted transvesical prostatectomy is a feasible and safe option for the treatment of BPH. In patients with large adenomas, it may represent an effective alternative to other surgical techniques. Further clinical evaluation is required to better define its role, particularly in comparison with HoLEP.

Keywords: benign prostatic hyperplasia – robot – transvesical prostatectomy

Received: December 17, 2025; Revised: January 29, 2026; Accepted: February 3, 2026; Prepublished online: March 3, 2026 



video



References

  1. European Association of Urology. EAU Guidelines on management of non-neurogenic male LUTS: Disease management. [online]. Arnhem: EAU Guidelines Office 2024. Available from: https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts/chapter/disease-management.
  2. Kordan Y, Canda AE, Köseoğlu E et al. Robotic-assisted simple prostatectomy: a systematic review. J Clin Med 2020; 9(6): 1798. doi: 10.3390/jcm9061798. Go to original source... Go to PubMed...
  3. Hartung FO, Egen L, Breuer L et al. Holmium laser enucleation of the prostate (HoLEP) compared to robot-assisted simple prostatectomy (RASP): a propensity score matched analysis. Aktuelle Urol 2025; 56(5): 464-469. doi: 10.1055/a-2577-3748. Go to original source... Go to PubMed...
  4. Khalil MI, Chase A, Joseph JV et al. Standard multiport vs single-port robot-assisted simple prostatectomy: a single-center initial experience. J Endourol 2022; 36(8): 1057-1062. doi: 10.1089/end.2021.0510. Go to original source... Go to PubMed...





Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.



Odejít Vstoupit